Clinical, Aesthetic, and Regenerative Applications of Medical Foods in Dermatology

Introduction: Prescription medical foods are naturally derived, disease-specific therapeutics regulated by the FDA under the Orphan Drug Act and used under physician oversight. Our aim is to define prescription medical foods (PMFs) as a distinct regulatory category and examine their established clinical indications, aesthetic benefits, and regenerative properties. This narrative review presents practical applications of three PMF ingredients in dermatology: diosmin-PMF, curcumin-PMF, and genistein-PMF. Methods: We conducted a comprehensive literature search on diosmin, curcumin, and genistein using PubMed to identify regulatory governance, bioavailability data, preclinical and clinical evidence, and dermatology applications. Additional articles were included through citation tracking and supplemented with the authors' clinical experience. Results: Diosmin-PMF is best established in chronic venous disease, improving venous symptoms, edema, stasis dermatitis, and ulcer healing, with proposed benefit in pigmented purpuric dermatoses, rosacea, and senile purpura via vascular-protective, anti-inflammatory activity. Aesthetically, it improves stasis-related hyperpigmentation and skin tone; regeneratively, it preserves the extracellular matrix by inhibiting matrix metalloproteinases, supporting ulcer repair. Curcumin-PMF shows broad anti-inflammatory activity in atopic dermatitis and psoriasis via NF-κB suppression, and has demonstrated benefit in autoimmune and fibrotic skin conditions. Aesthetically, it offers photoprotection and reduces UV-induced pigmentation; regeneratively, it modulates cellular senescence (SIRT1/mTOR) and enhances wound re-epithelialization and collagen remodeling. Genistein-PMF, a selective estrogen receptor-beta agonist, is primarily indicated for postmenopausal bone loss and vasomotor symptoms, with a favorable safety profile relative to conventional hormone therapy. Aesthetically, it improves skin elasticity and facial rhytids; regeneratively, it enhances collagen synthesis, wound healing, and shows early promise in hair restoration. Conclusion: Prescription medical foods represent a distinct, physician-supervised category bridging nutrition and pharmaceutical-grade regulation. Diosmin-PMF, curcumin-PMF, and genistein-PMF each show established clinical indications alongside overlapping aesthetic and regenerative benefits, driven by shared anti-inflammatory and antioxidant mechanisms. This convergence supports PMFs' potential to address disease-specific pathology and broader skin health within a single, physician-directed framework, with expansion to additional compounds warranting continued investigation.